Acta Scientific Cardiovascular System

Editorial Volume 1 Issue 7

Challenges of Anticoagulation in Thrombosis and Cancer - Cardiooncology View

Marcos J P Renni*

Clinical Research Division - INCA - National Institute of Cancer, Brazil

*Corresponding Author: Marcos J P Renni, Clinical Research Division - INCA - National Institute of Cancer, Brazil.

Received: October 26, 2022; Published: November 01, 2022

×

Cancer-associated venous thromboembolism is a common and life-threatening condition in patients with cancer. These patients have four to seven times more chance to develop VTE than patients without cancer. The factors responsible for the increased incidence of cancer associated VTE basically include the type of cancer and the ongoing antineoplastic treatment. The etiology of dysregulated hemostasis in cancer is multifactorial and has been associated with disease extent, tumor biology, local and systemic inflammation, cancer therapy, and patient-related factors.

×

References

×

Citation

Citation: Marcos J P Renni. “Challenges of Anticoagulation in Thrombosis and Cancer - Cardiooncology View". Acta Scientific Cardiovascular System 1.7 (2022): 01.



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US